Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
Resource Type
Article
Authors
Bethune, Claire ; Boffito, Marta ; Bula, Marcin ; Burns, Fiona M ; Clark, Rebecca ; Dasyam, Dileep ; Drysdale, Simon ; Faust, Saul ; Gkrania-Klotsas, Effrossyni ; Green, Christopher ; Hassanin, Hana ; Heath, Paul ; Heer, Amardeep ; Helliwell, Toby ; Hormis, Anil ; Kalra, Philip ; Lazarus, Rajeka ; Moran, Ed ; Ndikum, John ; Page, Iain ; Price, David ; Probert, Nick ; Ramjee, Mahadev ; Rampling, Tommy ; Randeva, Harpal S ; Ryder, Stephen ; Steer, John ; Thompson, Emma ; Torku, David ; Querton, Benedicte ; Corbic Ramljak, Irena ; Dewasthaly, Shailesh ; Jaramillo, Juan Carlos ; Dubischar, Katrin ; Krammer, Michael ; Weisova, Petronela ; Hochreiter, Romana ; Eder-Lingelbach, Susanne ; Taucher, Christian ; Finn, Adam
Source
In The Lancet Infectious Diseases December 2022 22(12):1716-1727
Subject
Primary Research Articles
Language
ISSN
1473-3099